Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

van Assen, Sander, Holvast, Albert, Benne, Cornelis A., Posthumus, Marcel D., van Leeuwen, Miek A., Voskuyl, Alexandre E., Blom, Marlies, Risselada, Anke P. +4 more·2010·Arthritis & Rheumatism

DOI 10.1002/art.25033

Cited by (371)

Items 101–200 of 371

Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis
Roxane Claverie, Marine Perriguey, Audrey Rico, Clémence Boutière, Sarah Demortière, Pierre Durozard, Frédéric Hilézian, Cléa Dubrou, Frédéric Vely, Jean Pelletier et al. · 2023 · Neurology Neuroimmunology & Neuroinflammation
Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
Dejan Jakimovski, Bianca Weinstock‐Guttman, Murali Krishna Ramanathan, Michael G. Dwyer, Robert Zivadinov · 2020 · Vaccines
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis
Laura Dell’Era, Fabrizia Corona, Cristina Daleno, Alessia Scala, Nicola Principi, Susanna Esposito · 2011 · Vaccine
Good and bad memories following rituximab therapy
E. William St. Clair · 2009 · Arthritis & Rheumatism
Hairy cell leukemia: Update on molecular profiling and therapeutic advances
Michael R. Grever, James Stewart Blachly, Leslie Ann Andritsos · 2014 · Blood Reviews
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis
Marwan A S Bukhari, Rikki Abernethy, Chris Deighton, T. Ding, Kimme Leanne Hyrich, Mark Lunt, Raashid Ahmed Luqmani, Patrick D W Kiely, A. Bosworth, Joanna M. Ledingham et al. · 2011 · Lara D. Veeken
Impfungen bei Immundefekten/Immunsuppression – Expertenstatement und Empfehlungen
Ursula Wiedermann, Harald H. Sitte, Heinz Burgmann, Alexander Eser, Petra Falb, Heidemarie Holzmann, Maria Kitchen, Marcus D Köller, Herwig Kollaritsch, Michael Kundi et al. · 2016 · Wiener klinische Wochenschrift
Immune cell repertoires in breast cancer patients after adjuvant chemotherapy
Claire E. Gustafson, Rohit R. Jadhav, Wenqiang Cao, Qian Qi, Mark Daniel Pegram, Lü Tian, Cornelia M. Weyand, Jörg J. Goronzy · 2020 · JCI Insight
An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology
Louise M. Gresham, Barbara Marzario, Jan Peter Dutz, Mark G. Kirchhof · 2021 · Journal of the American Academy of Dermatology
The Immunosuppressed Traveler
Leo G. Visser · 2012 · Infectious Disease Clinics of North America
Rituximab in systemic autoimmune rheumatic diseases: indications and practical use
Nathalie Berghen, Jean‐Baptiste Vulsteke, René Westhovens, Jan Lenaerts, Ellen De Langhe · 2018 · Acta Clinica Belgica
Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study
Martin Feuchtenberger, Stefan Kleinert, Sven Schwab, Petra Roll, E. Scharbatke, Eva Ostermeier, Reinhard Edmund Voll, Arne Schäfer, Hans‐Peter Tony · 2011 · Rheumatology International
Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases
Nicole M. Harrison, Wolfgang Poeppl, Manuel Miksch, Klaus Peter Machold, Hans Peter Kiener, Daniel Aletaha, Josef S Smolen, Christina Forstner, Heinz Burgmann, Heimo Lagler · 2018 · Vaccine
Are Anti-Infectious Vaccinations Safe and Effective in Patients with Autoimmunity?
Simonetta Salemi, Raffaele D’Amelio · 2010 · International Reviews of Immunology
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy
Nicola Giesen, Rosanne Sprute, Maria Madeleine Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, Catherina Lueck, Michael Koldehoff, Marcus Hentrich, Michael Sandherr et al. · 2021 · European Journal of Cancer
Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies
Janie Parrino, Shelly McNeil, Steven J. Lawrence, Eva K. Kimby, Marco F. Pagnoni, Jon E. Stek, Yanli Zhao, Ivan S. F. Chan, Susan S. Kaplan · 2017 · Vaccine
Avoidance of Harm From Treatment for ANCA-Associated Vasculitis
Catherine King, Lorraine Harper · 2017 · Current Treatment Options in Rheumatology
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
Zsuzsanna Hortobagyi McMahan, Clifton O. Bingham · 2014 · Arthritis Research & Therapy
A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review
Mehmet Soy, Gökhan Keser, Pamir Atagündüz, Melek Yalçın Mutlu, Alper Gündüz, Gizem Köybaşı, Cemal Beş · 2021 · Clinical Rheumatology
Vaccinations for Rheumatoid Arthritis
Lisa Perry, Kevin L. Winthrop, Jeffrey R. Curtis · 2014 · Current Rheumatology Reports
Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies
Paolo Pellegrino, Carla Carnovale, Valentina Perrone, Marco Pozzi, Stefania Antoniazzi, Sonia Radice, Emilio Clementi · 2014 · Vaccine
Efficacy and Safety of Hepatitis B Vaccination in Rheumatoid Arthritis Patients Receiving Disease-Modifying Antirheumatic Drugs and/or Biologics Therapy
Samanan Intongkam, Parinya Samakkarnthai, Rattapol Pakchotanon, Pongthorn Narongroeknawin, Paijit Asavatanabodee, Sumapa Chaiamnuay · 2018 · JCR Journal of Clinical Rheumatology
Vaccination recommendations for adult patients with rheumatic diseases
Mine Durusu Tanrıöver, Servet Akar, Nuran Türkçapar, Ömer Karadağ, İhsan Ertenli, Sedat Kiraz · 2016 · European Journal of Rheumatology
From mechanism to therapies in systemic lupus erythematosus
Michael Paley, Vibeke Strand, Alfred H.J. Kim · 2017 · Current Opinion in Rheumatology
Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
Jérôme Barrière, Daniel Ré, Frédéric Peyrade, Michel Carlès · 2021 · European Journal of Cancer
Effect of DMARDs on the immunogenicity of vaccines
Yannick van Sleen, Kornelis S. M. van der Geest, Anke L. W. Huckriede, Debbie van Baarle, Elisabeth Brouwer · 2023 · Nature Reviews Rheumatology
Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis
Yafang Huang, Huili Wang, Wilson Tam · 2017 · Current Medical Research and Opinion
Travel and biologic therapy: travel-related infection risk, vaccine response and recommendations
Victoria G. Hall, Douglas Forsyth Johnson, Joseph Torresi · 2018 · Journal of Travel Medicine
Current and emerging biologics for the treatment of juvenile idiopathic arthritis
Rolando Cimaz, Gabriella Maioli, Giulia Calabrese · 2020 · Expert Opinion on Biological Therapy
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements
Franco Dammacco, Gianfranco Lauletta, Angelo Vacca · 2022 · Clinical and Experimental Medicine
Steady state generation of mucosal IgA+ plasmablasts is not abrogated by B cell depletion therapy with rituximab
Henrik E. Mei, Daniela Frölich, Claudia Giesecke‐Thiel, Christoph Loddenkemper, Karin Reiter, Stefanie Schmidt, Eugen Feist, Capucine Daridon, Hans‐Peter Tony, Andreas Radbruch et al. · 2011 · Annals of the Rheumatic Diseases
Vaccination of children and adolescents with rheumatic diseases
Laura Dell’Era, Susanna Esposito, Fabrizia Corona, Nicola Principi · 2011 · Lara D. Veeken
Influenza Vaccination in Autoimmune Rheumatic Disease Patients
Milomir Milanović, Ljudmila Stojanovich, Aleksandra Djoković, Milica Kontić, Eleonora Gvozdenović · 2012 · The Tohoku Journal of Experimental Medicine
What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
Joost Frans Swart, Sytze de Roock, Nico Martinus Wulffraat · 2013 · Arthritis Research & Therapy
To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis
Qian Zhou, Ran Zhou, Haojun Yang, Huan Yang · 2021 · Frontiers in Immunology
Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: results of a claims data analysis
Andres Luque Ramos, Falk Hoffmann, Johanna Callhoff, A. Zink, Katinka Albrecht · 2016 · Rheumatology International
Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab
Victoria Furer, Devy Zisman, Ilana Kaufman, Uri Arad, Mark Berman, Hagit Sarbagil‐Maman, Muna Elias, Amir Haddad, Daphna Paran, Yaron Drori et al. · 2019 · Vaccine
Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists
Omid Zahedi Niaki, Milan J. Anadkat, Steven T. Chen, Lindy Peta Fox, JOANNA LEE HARP, Robert G. Micheletti, Vinod E. Nambudiri, Helena B. Pasieka, Michi M. Shinohara, Misha A. Rosenbach et al. · 2020 · Journal of the American Academy of Dermatology
Possible therapeutic agents for COVID-19: a comprehensive review
Khaled Mosaad Elhusseiny, Fatma Abd‐Elshahed Abd‐Elhay, Mohamed Gomaa Kamel · 2020 · Expert Review of Anti-infective Therapy
The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults
Alvin Lee Day, Kevin L. Winthrop, Jeffrey R. Curtis · 2020 · Cleveland Clinic Journal of Medicine
Seroprotection After Hepatitis A Vaccination in Patients With Drug‐Induced Immunosuppression
Wouter van den Bijllaardt, H M Siers, Caroline Timmerman‐Kok, Franciscus G. Pessers, Gerard Natrop, Joep F. van Baars, Nynke Nutma, Douwe van der Werf, Elizabeth H. Gisolf · 2013 · Journal of Travel Medicine
Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases—a prospective multi-centre cohort study
Silja Bühler, Veronika K. Jaeger, Sabine Adler, Bettina Bannert, Carolin Brümmerhoff, Adrian Ciurea, Oliver Distler, Juliane K. Franz, Cem Gabay, Niels Hagenbuch et al. · 2019 · Lara D. Veeken
Secondary Hypogammaglobulinemia
Blanka M. Kaplan, Vincent Robert Bonagura · 2018 · Immunology and Allergy Clinics of North America
Lupus, vaccinations and COVID-19: What we know now
Alice Mason, Himashi Anver, May Lwin, Christopher R. Holroyd, Saul N. Faust, Christopher John Edwards · 2021 · Lupus
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patients
Jérôme Avouac, Corinne Miceli‐Richard, Alice Combier, Alexia Steelandt, O. Fogel, Alice‐Andrée Mariaggi, Jean–François Méritet, Flore Rozenberg, Anna Moltó, Yannick Allanore · 2021 · Lara D. Veeken
Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
Andreas Tolf, Anna Wiberg, Malin Müller, Faisal Hayat Nazir, Ivan Pavlović, Ida Laurén, Sara M. Mangsbo, Joachim Burman · 2022 · JAMA Network Open
Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations
Giuseppe Murdaca, Giovanni Noberasco, Dario Olobardi, Claudio Lunardi, Matteo Maule, Lorenzo Delfino, Massimo Triggiani, Chiara Cardamone, Devis Benfaremo, Gianluca Moroncini et al. · 2021 · Vaccines
Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review
Beatriz Garcillán, Miguel Salavert, José Ramón Regueiro, Sabela Díaz-Castroverde · 2022 · Vaccines
Vaccines and biologics
Isabel Ferreira, David Alan Isenberg · 2014 · Annals of the Rheumatic Diseases
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Alexandra Galati, Thomas Frederick McElrath, Riley M. Bove · 2022 · Neurology Clinical Practice
Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Dana Roll, Julia Ammer, Barbara Holler, Bernd Salzberger, Brunhilde Schweiger, Wolfgang Jilg, Reinhard Andreesen, Matthias Edinger, Daniel Wolff, Ernst Holler · 2011 · Infection
Impfung bei erwachsenen Patienten mit chronisch entzündlichen rheumatischen Erkrankungen
Kommission Pharmakotherapie der DGRh, Sigune Goldacker, Angela Gause, Klaus Warnatz · 2013 · Zeitschrift für Rheumatologie
Emerging drugs to treat juvenile idiopathic arthritis
Nicolino Ruperto, Alberto Martini · 2011 · Expert Opinion on Emerging Drugs
Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic
Hesham Abboud, Crystal Y. Zheng, Indrani Kar, Claire Kaori Chen, Crystal Sau, Alessandro Serra · 2020 · Multiple Sclerosis and Related Disorders
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, Thita Chiasakul, Ponlapat Rojnuckarin · 2022 · Blood Cancer Journal
Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis
John L. Niles · 2011 · Clinical & Experimental Immunology
Intradermal Vaccination to Protect Against Yellow Fever and Influenza
Anna H.E. Roukens, Luc B. S. Gelinck, Leo G. Visser · 2011 · Current topics in microbiology and immunology
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination
Christof Specker, Peer Malte Aries, Jürgen Braun, Gerd Rüdiger Burmester, Rebecca Fischer‐Betz, Rebecca Hasseli, Julia Ulrike Holle, Bimba F. Hoyer, Christof Iking‐Konert, Andreas Krause et al. · 2021 · Zeitschrift für Rheumatologie
Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy
Nina M. Bemben, Melody L. Berg · 2022 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Initial Management of Rheumatoid Arthritis
A Gramling, James R. O’Dell · 2012 · Rheumatic Disease Clinics of North America
Vaccinations for rheumatoid arthritis
Marcia Friedman, Kevin L. Winthrop · 2016 · Current Opinion in Rheumatology
B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use
Md Yuzaiful Md Yusof, Edward M J Vital, Maya H Buch · 2015 · Current Rheumatology Reports
B cell therapies for rheumatoid arthritis: beyond B cell depletion.
I. Calero, J. Nieto, I. Sanz · 2010 · Rheumatic Disease Clinics of North America
Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications
John E. McKinnon, Kathleen Maksimowicz‐McKinnon · 2015 · Translational research
Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer
Nicole M. Kuderer, Joshua Aiden Hill, Paul A. Carpenter, Gary H. Lyman · 2021 · Cancer Investigation
COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
Michael Manansala, Amit Chopra, Robert Phillip Baughman, Richard M. Novak, Elyse E. Lower, Daniel A. Culver, Peter Korsten, Wonder P. Drake, Marc A. Judson, Nadera Sweiss · 2021 · Frontiers in Medicine
Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients
Daryl Ray Cheng, Rebecca Barton, Anthea Louise Greenway, Nigel W. Crawford · 2016 · Expert Review of Vaccines
Pro: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?
Ulrich Specks · 2015 · Nephrology Dialysis Transplantation
Immunity 12 years after alemtuzumab in RA: CD5+ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses
Amy E. Anderson, Alice R. Lorenzi, Arthur G. Pratt, T. Wooldridge, Julie Diboll, Catharien M. U. Hilkens, John Dudley Isaacs · 2012 · Lara D. Veeken
The complications of vasculitis and its treatment
Catherine King, Lorraine Harper, Mark Alan Little · 2018 · Best Practice & Research Clinical Rheumatology
A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia
Peter K. K. Wong, Hanish Bagga, Claire Barrett, Paddy Hanrahan, Doug Johnson, Amel Katrib, Karin S Leder, Mona Marabani, Peta Pentony, John Riordan et al. · 2017 · Internal Medicine Journal
High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial
Jack T. Stapleton, Nancy Wagner, Rebecca S. Tuetken, Abbie R. Bellamy, Heather Hill, Sonnie Kim, Patricia L. Winokur · 2020 · Vaccine
The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis
Ithamar Brinkman, Mart A F J van de Laar, Tim Jansen, Eric Nico van Roon · 2011 · Expert Opinion on Drug Safety
Immunization in Special Populations
Michael A. Miller, Mobeen H. Rathore · 2012 · Advances in Pediatrics
Vaccinations in Selected Immune-Related Diseases Treated with Biological Drugs and JAK Inhibitors—Literature Review and Statement of Experts from Polish Dermatological Society
Joanna Narbutt, Zbigniew Michał Żuber, Aleksandra Lesiak, Natalia Bień, Jacek Cezary Szepietowski · 2024 · Vaccines
Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.
Rüdiger Müller, Reinhard Maier, Katja Höschler, Maria Cristina Fleischmann Alves Zambon, Burkhard Ludewig, Martin Herrmann i, Hendrik Schulze‐Koops, Johannes von Kempis · 2013 · PubMed
B-cell depletion therapy for multiple sclerosis
Yusei Miyazaki, Masaaki Niino · 2021 · Immunological Medicine
BNT162b2 mRNA COVID‐19 vaccine booster induces seroconversion in patients with B‐cell non‐Hodgkin lymphoma who failed to respond to two prior vaccine doses
Irit Mazza Avivi, Efrat Luttwak, Esther Saiag, Tami Halperin, Shira Haberman, Ariel Sarig, Sivan Levi, Anat Aharon, Yair Herishanu, Chava Perry · 2022 · British Journal of Haematology
Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?
Andreas Kronbichler, David R.W. Jayne · 2015 · Nephrology Dialysis Transplantation
Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations)
Sander van Assen, Marc Bijl · 2012 · Lupus
Risk Factors and Approaches to Infections in Transplant Recipients
J. Stephen Dummer, Lora D. Thomas · 2015 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients—a 6-month follow-up prospective study
Katja Lakota, Katja Perdan Pirkmajer, Snežna Sodin‐Šemrl, Saša Čučnik, V. Šubelj, Katarina Prosenc, Katjuša Mrak‐Poljšak, Matija Tomšič, Aleš Ambrožič, Sonja Praprotnik · 2019 · Clinical Rheumatology
Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case–control study (COVID-19VacRTX)
Falk Schumacher, Nikola Mrdenovic, Dennis Scheicht, Jörn Pons‐Kühnemann, Christine Scheibelhut, Johannes Strunk · 2022 · Lara D. Veeken
How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease
J. Richards, S. Dowell, M. Quiñones, G. Kerr · 2015 · British medical journal
If and When to Consider Prophylactic Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
Iris M. Otani, Mark C. Ballow · 2024 · The Journal of Allergy and Clinical Immunology In Practice
Acute and chronic inflammatory neuropathies and COVID ‐19 vaccines: Practical recommendations from the task force of the Italian Peripheral Nervous System Association ( ASNP )
Pietro Emiliano Doneddu, Emanuele Spina, Chiara Briani, Gian Maria Fabrizi, Fiore Manganelli, Eduardo Nobile‐Orazio · 2021 · Journal of the Peripheral Nervous System
Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications
Elle Levit, Erin E. Longbrake, Sharon S. Stoll · 2022 · Multiple Sclerosis and Related Disorders
Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies
João Marcello de Araújo-Neto, Gabriela Sousa Guimarães, Flavia Ferreira Fernandes, Marcelo Alves Soares · 2022 · Viruses
CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell–Mediated CD4 T Cell Responses
Kuan Yau Wong, Rebecca Baron, Therese A. Seldon, Martina L. Jones, Alison M. Rice, David J. Munster · 2018 · The Journal of Immunology
The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
Yu Bin Seo, Su‐Jin Moon, Chan Hong Jeon, Joon Young Song, Yoon‐Kyoung Sung, Su Jin Jeong, Ki Tae Kwon, Eu Suk Kim, Jae-Hoon Kim, Hyoun‐Ah Kim et al. · 2020 · Infection and Chemotherapy
B cell depletion in immune-mediated rheumatic diseases and coronavirus disease 2019 (COVID-19)
Evgeny Lvovich Nasonov, Anastasia Sergeevna Avdeeva · 2021 · Rheumatology Science and Practice
Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature
Dorra Ben Nessib, Alia Fazaa, S. Miladi, Meriem Sellami, Kmar Ouenniche, Leila Souabni, Salma Kassab, Salma Chekili, K. Ben Abdelghani, A. Laatar · 2020 · Therapies
Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system
Jéfferson Becker, Lis Campos Ferreira, Alfredo Damasceno, Denis Bernardi Bichuetti, Paulo Pereira Christo, Dagoberto Callegaro, Marco Aurélio Lana–Peixoto, Nise Alessandra de Carvalho Sousa, Sérgio Monteiro de Almeida, Tarso Adoni et al. · 2021 · Arquivos de Neuro-Psiquiatria
Immunization in patients with inflammatory rheumatic diseases
Κonstantinos Thomas, Dimitrios Vassilopoulos · 2016 · Best Practice & Research Clinical Rheumatology
Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies
Xueyi Huang, Xiaoqian Liang, Jiao Zhang, Hang Su, Yongfeng Chen · 2022 · Journal of Clinical Medicine
Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases
Ichiro Kobayashi, Masaaki Mori, Kenichi Yamaguchi, Shuichi Ito, Naomi Iwata, Kenji Masunaga, Naoki Shimojo, Tadashi Ariga, Kenji Okada, Shuji Takei · 2014 · Modern Rheumatology
Literature‐based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses
Valerie Laniosz, Julia Scott Lehman, Gregory A. Poland, David A. Wetter · 2015 · International Journal of Dermatology
Vaccination in neuromyelitis optica spectrum disorders: Friend or enemy?
Haobing Cai, Ran Zhou, Fei Jiang, Qiuming Zeng, Huan Yang · 2021 · Multiple Sclerosis and Related Disorders
Treatment of Myasthenia Gravis Patients with COVID-19: Review of the Literature
Sven Županić · 2021 · Acta Clinica Croatica
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
Federica Filippini, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Cesare Tomasi, Franco Franceschini, Arnaldo Caruso, Ilaria Cavazzana, Cinzia Giagulli · 2023 · BMC Medicine